Author/Authors :
Alvarez، نويسنده , , Y. and Coll، نويسنده , , M.D. and Ortega، نويسنده , , J.J. and Bastida، نويسنده , , P. and Dastugue، نويسنده , , N. and Robert، نويسنده , , A. and Cervera، نويسنده , , J. and Verdeguer، نويسنده , , A. and Tasso، نويسنده , , M. and Aventيn، نويسنده , , A. and Guitart، نويسنده , , M. and Caballيn، نويسنده , , M.R.، نويسنده ,
Abstract :
The ETV6/RUNX1 rearrangement is found in 20–30% of children with B-cell precursor acute lymphoblastic leukemia and is associated with a good outcome. To determine the cytogenetic and molecular abnormalities associated with the ETV6/RUNX1 rearrangement and the influence of this rearrangement in patientsʹ evolution, we analyzed the molecular cytogenetic profiles of 56 children with this rearrangement and B-cell precursor acute lymphoblastic leukemia. Secondary changes detected with conventional cytogenetics and with fluorescence in situ hybridization were found in 71.4% of cases, the most frequent being the loss of the normal ETV6 allele, 12p aberrations, duplication of the fusion gene, and trisomy 21, as in replicating the results of previous studies. In this preliminary series, with a mean follow-up of 69.3 months, secondary abnormalities did not influence patientsʹ outcome. It seems therefore that the prognostic value of the t(12;21) does not vary and that ETV6/RUNX1 rearrangement is an independent indicator of good prognosis.
